The age of stem cell acceptance has arrived. Last week shares of OncoMed Pharmaceuticals, Inc. soared over 100%, moving from a $14.00 close on December 2nd to an intraday high of $32.39 on December 4th.
http://seekingalpha.com/article/1912541-neostem-stands-to-benefit-from-stem-cell-deals?source=feed
http://seekingalpha.com/article/1912541-neostem-stands-to-benefit-from-stem-cell-deals?source=feed
No comments:
Post a Comment